GlassScriptPhysician profile
Beena S Jacob
NPI 1770509200
$28,355.93
in general payments reported to CMS, 2019-2025
33 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $644 · 2022: $1,877 · 2023: $2,882 · 2024: $6,186 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $11K · Education: $376 · Travel and Lodging: $6.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,800.00 |
| Food and Beverage | $10,652.63 |
| Education | $375.98 |
| Travel and Lodging | $6.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $16,303.00 | 2024-2025 | Daxxify, Daxi |
| Incyte Corporation | $1,901.01 | 2021-2025 | Opzelura |
| Merz North America, INC. | $1,348.66 | 2023-2024 | Xeomin |
| Galderma Laboratories, L.P. | $1,334.61 | 2021-2025 | Epsolay, Aklief, Nemluvio |
| Dermavant Sciences, INC. | $904.41 | 2022-2024 | Vtama |
| Pfizer INC. | $845.75 | 2021-2025 | |
| Abbvie INC. | $721.07 | 2021-2025 | |
| Janssen Biotech, INC. | $538.60 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Arcutis Biotherapeutics, INC. | $489.16 | 2023-2025 | Zoryve |
| Almirall LLC | $464.89 | 2021-2025 | Klisyri, Seysara |
| Genzyme Corporation | $424.69 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $422.73 | 2021-2025 | Absorica Ld, Winlevi |
| Lilly USA, LLC | $358.81 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Novartis Pharmaceuticals Corporation | $274.91 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $259.37 | 2022-2024 | Sotyktu |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $237.81 | 2021 | |
| Amgen INC. | $187.08 | 2022-2025 | Otezla, Otezla |
| Leo Pharma INC. | $182.92 | 2022-2024 | Adbry |
| Regeneron Healthcare Solutions, INC. | $182.12 | 2022-2025 | Dupixent |
| Organon LLC | $148.77 | 2025 | Vtama |
| Janssen Scientific Affairs, LLC | $124.70 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.73 | 2024-2025 | Spevigo |
| Sanofi-Aventis U.S. LLC | $83.00 | 2024 | |
| Journey Medical Corporation | $82.52 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $73.70 | 2022-2025 | |
| Verrica Pharmaceuticals INC. | $70.66 | 2024-2025 | Ycanth |
| Ucb, INC. | $69.61 | 2024 | Bimzelx |
| Epi Health, LLC | $66.76 | 2021-2022 | |
| Botanix Sb INC | $62.54 | 2025 | Sofdra |
| Allergan, INC. | $35.73 | 2022 | |
| Ani Pharmaceuticals, INC. | $19.91 | 2025 | Oxistat |
| Tempus Ai, INC | $16.18 | 2024 | Merlin Test |
| Lnhc, INC | $15.52 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beena Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.